MY
Myriad Genetics, Inc.
MYGN · NASDAQ
$4.01 +2.04% (+$0.08)
1M +31.48%
Market Cap $378.7M
P/E Ratio -
Div. Yield -
ROE 32.59%
Bulios Fair Price
$4.08
1.7% upside
Trenutna cena
$4.01
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica MYGN trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 1.25x
P/S 0.47x
P/FFO N/A
Growth
41 /100
Stable Book val. growth 25.38%
Rev. growth 6.72%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 12.22%
Gross margin 68.83%
FCF margin 1.07%
Quality
15 /100
Poor ROA 17.62%
ROIC 19.26%
Asset turnover 1.26x
Debt
55 /100
Moderate Int. coverage -5.82x
Debt/Equity 0.69x
Current ratio 2.21x
Stability
35 /100
Moderate EPS volatility 124.28%
Beta 1.68x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MYGN
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Samraat S. Raha
Employees
2,700
Headquarters
Salt Lake City
Prihajajoči dogodki
02 NOV.
Earnings
Upcoming earnings report